Cargando…
Molecularly precise self-assembly of theranostic nanoprobes within a single-molecular framework for in vivo tracking of tumor-specific chemotherapy
Structural heterogeneity and the lack of in vivo real-time tracking of drug release are the utmost barriers for nanocarrier-mediated prodrugs in targeted therapy. Herein, we describe the strategy of molecularly precise self-assembly of monodisperse nanotheranostics for BP(n)-DCM-S-CPT (n = 0, 5 and...
Autores principales: | Yan, Chenxu, Guo, Zhiqian, Shen, Yanyan, Chen, Yi, Tian, He, Zhu, Wei-Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989654/ https://www.ncbi.nlm.nih.gov/pubmed/29938023 http://dx.doi.org/10.1039/c8sc01069b |
Ejemplares similares
-
Nanoprobes for Tumor Theranostics
por: Zhu, Jiaoyang, et al.
Publicado: (2022) -
Dual-channel NIR activatable theranostic prodrug for in vivo spatiotemporal tracking thiol-triggered chemotherapy
por: Ye, Mingzhou, et al.
Publicado: (2016) -
Tunable Plasmonic Nanoprobes for Theranostics of Prostate Cancer
por: Lukianova-Hleb, Ekaterina Y., et al.
Publicado: (2011) -
Retraction of “Tunable Plasmonic Nanoprobes for Theranostics of Prostate Cancer”
por: Lukianova-Hleb, Ekaterina Y., et al.
Publicado: (2017) -
Activatable near-infrared emission-guided on-demand administration of photodynamic anticancer therapy with a theranostic nanoprobe
por: Wang, Rongchen, et al.
Publicado: (2019)